Andrezza V. Belo

424 total citations
17 papers, 325 citations indexed

About

Andrezza V. Belo is a scholar working on Molecular Biology, Immunology and Obstetrics and Gynecology. According to data from OpenAlex, Andrezza V. Belo has authored 17 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Obstetrics and Gynecology. Recurrent topics in Andrezza V. Belo's work include Reproductive System and Pregnancy (5 papers), Uterine Myomas and Treatments (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Andrezza V. Belo is often cited by papers focused on Reproductive System and Pregnancy (5 papers), Uterine Myomas and Treatments (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Andrezza V. Belo collaborates with scholars based in Brazil, United Kingdom and United States. Andrezza V. Belo's co-authors include Sílvia Passos Andrade, Mônica Alves Neves Diniz Ferreira, Agnaldo Lopes da Silva Filho, Mauro Martins Teixeira, Lucíola S. Barcelos, Andréia Teixeira, W. T. Beraldo, Márcia Mendonça Carneiro, Sérgio A. Triginelli and Maria Aparecida Gomes and has published in prestigious journals such as Gut, Life Sciences and Fertility and Sterility.

In The Last Decade

Andrezza V. Belo

16 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrezza V. Belo Brazil 12 110 68 61 57 54 17 325
Antonia Sioga Greece 10 82 0.7× 68 1.0× 81 1.3× 52 0.9× 25 0.5× 54 383
Carlotta Boscaro Italy 8 116 1.1× 26 0.4× 70 1.1× 43 0.8× 21 0.4× 15 352
Qijing Wang China 13 164 1.5× 49 0.7× 123 2.0× 70 1.2× 39 0.7× 27 402
Ye Gan China 11 190 1.7× 28 0.4× 108 1.8× 39 0.7× 33 0.6× 17 481
Tao Mei China 8 129 1.2× 36 0.5× 44 0.7× 58 1.0× 19 0.4× 23 309
Keren Bahar‐Shany Israel 8 92 0.8× 83 1.2× 39 0.6× 47 0.8× 18 0.3× 9 315
Gülçin Şımşek Türkiye 11 96 0.9× 25 0.4× 26 0.4× 51 0.9× 23 0.4× 76 349
Yeke Wu China 9 139 1.3× 40 0.6× 45 0.7× 22 0.4× 24 0.4× 20 323
Lirong Ren China 12 150 1.4× 14 0.2× 29 0.5× 33 0.6× 41 0.8× 28 328
Bo Pang China 13 142 1.3× 59 0.9× 175 2.9× 77 1.4× 24 0.4× 26 462

Countries citing papers authored by Andrezza V. Belo

Since Specialization
Citations

This map shows the geographic impact of Andrezza V. Belo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrezza V. Belo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrezza V. Belo more than expected).

Fields of papers citing papers by Andrezza V. Belo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrezza V. Belo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrezza V. Belo. The network helps show where Andrezza V. Belo may publish in the future.

Co-authorship network of co-authors of Andrezza V. Belo

This figure shows the co-authorship network connecting the top 25 collaborators of Andrezza V. Belo. A scholar is included among the top collaborators of Andrezza V. Belo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrezza V. Belo. Andrezza V. Belo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Belo, Andrezza V., Sílvia Passos Andrade, Paula Peixoto Campos, et al.. (2014). Identification of local angiogenic and inflammatory markers in the menstrual blood of women with endometriosis. Biomedicine & Pharmacotherapy. 68(7). 899–904. 21 indexed citations
2.
Belo, Andrezza V., et al.. (2013). N-acetylglucosaminidase, myeloperoxidase and vascular endothelial growth factor serum levels in breast cancer patients. Biomedicine & Pharmacotherapy. 68(2). 185–189. 11 indexed citations
3.
Carneiro, Márcia Mendonça, et al.. (2013). Identification of local angiogenic and inflammatory markers in the menstrual blood of women with endometriosis. Fertility and Sterility. 100(3). S367–S367. 1 indexed citations
4.
Pontes, Anaglória, et al.. (2012). Evaluation of N‐acetilglucosaminidase and myeloperoxidase activity in patients with endometriosis‐related infertility undergoing intracytoplasmic sperm injection. Journal of obstetrics and gynaecology research. 38(5). 810–816. 14 indexed citations
5.
Pontes, Anaglória, Andrezza V. Belo, Sílvia Passos Andrade, et al.. (2012). Inflammatory Response Patterns in ICSI Patients: A Comparative Study Between Chronic Anovulating and Normally Ovulating Women. Reproductive Sciences. 19(7). 704–711. 10 indexed citations
6.
Belo, Andrezza V., et al.. (2011). Analysis of systemic inflammatory response in the carcinogenic process of uterine cervical neoplasia. Biomedicine & Pharmacotherapy. 65(7). 496–499. 15 indexed citations
7.
Amaral, Liliany Souza de Brito, et al.. (2009). Metformin inhibits inflammatory angiogenesis in a murine sponge model. Biomedicine & Pharmacotherapy. 64(3). 220–225. 55 indexed citations
8.
Filho, Agnaldo Lopes da Silva, et al.. (2006). Abdominal vs vaginal hysterectomy: a comparative study of the postoperative quality of life and satisfaction. Archives of Gynecology and Obstetrics. 274(1). 21–24. 29 indexed citations
9.
Belo, Andrezza V., Lucíola S. Barcelos, Mônica Alves Neves Diniz Ferreira, et al.. (2005). Murine Chemokine CXCL2/KC Is a Surrogate Marker for Angiogenic Activity in the Inflammatory Granulation Tissue. Microcirculation. 12(7). 597–606. 26 indexed citations
10.
Belo, Andrezza V., et al.. (2005). Gastroprotective effects of oral nucleotide administration. Gut. 55(2). 165–171. 15 indexed citations
11.
Belo, Andrezza V., Lucíola S. Barcelos, Mauro Martins Teixeira, Mônica Alves Neves Diniz Ferreira, & Sílvia Passos Andrade. (2004). Differential Effects of Antiangiogenic Compounds in Neovascularization, Leukocyte Recruitment, VEGF Production, and Tumor Growth in Mice. Cancer Investigation. 22(5). 723–729. 16 indexed citations
12.
Belo, Andrezza V., Lucíola S. Barcelos, Mônica Alves Neves Diniz Ferreira, Mauro Martins Teixeira, & Sílvia Passos Andrade. (2004). Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice. Life Sciences. 74(23). 2827–2837. 30 indexed citations
13.
Ferreira, Mônica Alves Neves Diniz, et al.. (2002). Vasodilator effect of angiotensin-(1–7) in mature and sponge-induced neovasculature. Regulatory Peptides. 107(1-3). 105–113. 16 indexed citations
14.
Belo, Andrezza V., et al.. (2001). Differential Effects of Thalidomide on Angiogenesis and Tumor Growth in Mice. Inflammation. 25(2). 91–96. 12 indexed citations
15.
Belo, Andrezza V., et al.. (1998). Clotrimazole is an Inhibitor of Inflammatory Angiogenesis and the Metabolic Activity in Sponge Granuloma. Inflammation. 22(6). 643–651. 6 indexed citations
16.
Andrade, Sílvia Passos, et al.. (1997). Sponge-Induced Angiogenesis in Mice and the Pharmacological Reactivity of the Neovasculature Quantitated by a Fluorimetric Method. Microvascular Research. 54(3). 253–261. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026